About us

---

APRHPSC is a pioneering research and public health strategy institution based in Thailand with a scope encompassing the Asia-Pacific region. We are dedicated to bridging the critical lacuna between Clinical Medicine and Public Health. By integrating the macro-vision of Population Science with the micro-precision of Evidence-Based Medicine (EBM), we provide scientific, full-cycle solutions for fertility preservation.

Distinct from traditional Assisted Reproductive Technology (ART) institutions that focus solely on "treatment," APRHPSC adheres to the scientific philosophy of "Prevention First, Stratified Intervention." We posit that true reproductive health management must commence prior to clinical medical intervention.

Our research and service architecture is founded on two parallel, indispensable tracks:

1. Public Health & Non-Medical Intervention (Targeting Natural Conception / Sub-optimal Health Populations)We recognize that many cases of hypofertility do not require aggressive medical intervention. Leveraging population science methodologies, we are committed to developing "Low-Cost, High-Efficiency" Primary Prevention Strategies:

• Health Education & Cognitive Reshaping: Developing reproductive health curricula tailored to diverse demographics to correct cognitive biases regarding fertility and promote scientific preconception knowledge.
• Lifestyle Medicine: Establishing data-driven lifestyle intervention models. Targeting risk factors such as obesity, metabolic disorders, and exposure to environmental endocrine disruptors, we formulate precise non-pharmacological intervention regimes (e.g., exercise prescriptions, nutritional planning, sleep management) to facilitate natural conception through physiological optimization.
• Fertility Preservation Strategy: Providing public health-oriented fertility assessment and planning for the reproductive-age population, advocating for age-appropriate childbearing to reduce the incidence of infertility at the source.

2. Clinical Reproductive Medicine Research & Standardization — Reshaping Clinical Decisions with Public Health LogicFor cohorts requiring Assisted Reproductive Technology (ART), we do not merely pursue technological accumulation. Instead, we introduce Clinical Epidemiology and Risk Management into the entire medical process, striving for safer, more precise, and cost-effective clinical outcomes:

• Risk Stratification based on Clinical Epidemiology: Utilizing population big data to build predictive models for precise patient risk stratification prior to treatment initiation. We aim to identify and intervene in potential clinical risks (e.g., Ovarian Hyperstimulation Syndrome [OHSS], multiple pregnancy risks, embryonic genetic abnormalities, immune and metabolic risks, and risks associated with advanced maternal age or special populations), shifting from "remedial action" to "proactive prevention," thereby enhancing medical safety at the source.
• Evidence-based QA & SOPs: Introducing Public Health Quality Assurance (QA) systems into reproductive centers. By developing standardized Clinical Pathways, we eliminate diagnostic and therapeutic variances caused by individual practitioner experience. Our goal is to establish a replicable, quantifiable set of high-standard medical service specifications, ensuring every patient receives homogenized treatment based on the best available evidence.
• Health Economic Evaluation: We adhere to the public health principle of "Appropriate Medical Care." Through health economic evaluations of clinical protocols, we aim to eliminate ineffective or low-efficiency over-treatment, formulating Cost-Effective personalized treatment plans to return medicine to its essence of healing.
• Digital Therapeutics & Full-Cycle Management: Utilizing proprietary digital tools to collect Real-World Data (RWD) outside the hospital setting, extending medical care beyond the clinic to achieve a closed-loop management of physical and mental health.

• A — Asia Pacific (Regional Characteristic Spectrum):Constructing a comprehensive reproductive health database for the Asia-Pacific population based on ethnography and environmental epidemiology, precisely analyzing the impact of regional environments and dietary habits on fertility.
• RH — Reproductive Health (Holistic Reproductive Well-being):Redefining reproductive health—not merely as "curing disease," but as "preventive protection." We provide stratified solutions ranging from health education and lifestyle intervention to standardized clinical treatment.
• PSC — Population Science (The Core Soul): This is our ethos. We employ demographic statistical models and health economic evaluations to screen for the most cost-effective interventions. Our goal: to enable more families to realize their aspirations for life propagation through more natural, economical, and scientific means.

APRHPSC — The Planner of Family Fertility and the Driver of Industry Standard Optimization.

We not only empower clinical practice through research but are also dedicated to reducing unnecessary medical interventions through public health measures. We ensure that every aspiration for life finds its most suitable scientific path—whether it be a gift of nature or a miracle of medicine.